TG 100801 5mg 5mg | Purity Not Available
Adooq Bioscience
TG 100801 is a VEGFR2 targeting prodrug currently in a clinical trial. The active form is TG100572.
More Information Supplier PageSearch Results
TG 100801 25mg 25mg | Purity Not Available
Adooq Bioscience
TG 100801 is a VEGFR2 targeting prodrug currently in a clinical trial. The active form is TG100572.
More Information Supplier PageTG 100801 10mg 10mg | Purity Not Available
Adooq Bioscience
TG 100801 is a VEGFR2 targeting prodrug currently in a clinical trial. The active form is TG100572.
More Information Supplier PageVER-50589 5mg 5mg | Purity Not Available
Adooq Bioscience
VER-50589 is an isoxazole compound that inhibits Hsp90 with an IC50 value of 21 nM.
More Information Supplier PageVER-50589 25mg 25mg | Purity Not Available
Adooq Bioscience
VER-50589 is an isoxazole compound that inhibits Hsp90 with an IC50 value of 21 nM.
More Information Supplier PageVER-50589 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
VER-50589 is an isoxazole compound that inhibits Hsp90 with an IC50 value of 21 nM.
More Information Supplier PageVER-50589 10mg 10mg | Purity Not Available
Adooq Bioscience
VER-50589 is an isoxazole compound that inhibits Hsp90 with an IC50 value of 21 nM.
More Information Supplier PageTG 100572 25mg 25mg | Purity Not Available
Adooq Bioscience
TG 100572 5mg 5mg | Purity Not Available
Adooq Bioscience
CGP77675 10mg 10mg | Purity Not Available
Adooq Bioscience
CGP77675 is a potent Src kinase inhibitor. CGP77675 inhibited phosphorylation of peptide substrates and autophosphorylation of purified Src (IC50: 5-20 and 40 nM, respectively).
More Information Supplier Page